Coloplast AS (OTCPK:CLPBF)
$ 128.575 7.425 (6.13%) Market Cap: 28.76 Bil Enterprise Value: 31.84 Bil PE Ratio: 39.13 PB Ratio: 11.87 GF Score: 94/100

Q3 2024 Coloplast A/S Earnings Call Transcript

Aug 20, 2024 / 09:00AM GMT
Release Date Price: $128.6 (-3.71%)
Kristian Villumsen;S;President
Coloplast A;Chief Executive Officer, Member of the Executive Management

/- -

Good morning, everybody, and welcome to our nine-months '23-'24 conference call. I'm Kristian Villumsen, the CEO of Coloplast, and I'm joined by our CFO, Anders Lonning-Skovgaard and our Investor Relations team. We'll start with a short presentation by Anders and myself and then open up for questions like we usually do.

Please turn to slide number 3. We delivered 8% organic growth and a reported EBIT margin before special items of 27% in our third quarter. Return on invested capital after tax and before special items was 15%, reflecting impact from the acquisition of Kerecis. I'm satisfied with our performance, continue to broadly outgrow the market, and we're delivering solid growth in absolute profits. More importantly, we also continue to help a lot more people who live with intimate healthcare needs.

Let me start today's call with a few highlights. First, innovation. This is a year with several significant product launches that will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot